145 related articles for article (PubMed ID: 2285302)
1. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
Barry AL; Jones RN
Antimicrob Agents Chemother; 1990 Sep; 34(9):1830-2. PubMed ID: 2285302
[TBL] [Abstract][Full Text] [Related]
2. [Comparative in vitro activity of ampicillin, cefoperazone, their combinations with sulbactam and other antibiotics with respect to staphylococci and pneumococci].
Sidorenko SV; Rezvan SP; Speranskaia ON; Tikhonova As; Navashin SM; Ansolis LE; Tsvigun EA; Kuleshov SE; Budanov SV
Antibiot Khimioter; 1995 Mar; 40(3):22-7. PubMed ID: 7575010
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ampicillin/sulbactam and amoxicillin/clavulanic acid for detection of borderline oxacillin-resistant Staphylococcus aureus.
Liu H; Lewis N
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):47-51. PubMed ID: 1563385
[TBL] [Abstract][Full Text] [Related]
4. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Rezvan SP; Sidorenko SV; Budanov SV
Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
[TBL] [Abstract][Full Text] [Related]
5. Survey of clinical isolates of Staphylococcus aureus for borderline susceptibility to antistaphylococcal penicillins.
Varaldo PE; Montanari MP; Biavasco F; Manso E; Ripa S; Santacroce F
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):677-82. PubMed ID: 8243483
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
Segreti J; Kapell KS; Trenholme GM
Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antimicrobial studies with the combination of cefoperazone and sulbactam.
Greenberg RN; Baker M; Meade DW; Chang Y; Danko LS
J Antimicrob Chemother; 1993 Dec; 32(6):912-3. PubMed ID: 8144438
[No Abstract] [Full Text] [Related]
9. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
10. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of sulbactam/ampicillin and ampicillin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Fabbri A; Tacchella A; Belli ML; Losurdo G
Chemioterapia; 1988 Oct; 7(5):306-8. PubMed ID: 3224398
[TBL] [Abstract][Full Text] [Related]
12. Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.
Bradford PA; Sanders CC
Antimicrob Agents Chemother; 1992 Feb; 36(2):394-400. PubMed ID: 1605604
[TBL] [Abstract][Full Text] [Related]
13. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
Hirano L; Bayer AS
Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates.
Eliopoulos GM; Klimm K; Ferraro MJ; Moellering RC
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):624-6. PubMed ID: 2506024
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of penicillin G plus sulbactam in comparison with other beta-lactamase inhibitor combinations and oxacillin against staphylococci.
Jansen B; Perdreau-Remington F; Pulverer G
Zentralbl Bakteriol; 1996 Jul; 284(2-3):297-301. PubMed ID: 8837390
[TBL] [Abstract][Full Text] [Related]
16. Use of a predictor panel to evaluate susceptibility testing methods for ampicillin-sulbactam.
Bradford PA; Sanders CC
Antimicrob Agents Chemother; 1993 Feb; 37(2):251-9. PubMed ID: 8452355
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.
Pfaller MA; Barry AL; Fuchs PC; Gerlach EH; Hardy DJ; McLaughlin JC
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):356-62. PubMed ID: 8354303
[TBL] [Abstract][Full Text] [Related]
18. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
[TBL] [Abstract][Full Text] [Related]
19. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Jones RN; Salazar JC; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
